Vaccitech’s $168 Million Series B Financing Round

Vaccitech's $168 Million Series B Financing Round
Federica Tiefenthaler Europe, Europe Legal Chronicle
Tagged:

Goodwin Procter LLP advised Vaccitech on the deal. Vaccitech announced the completion of its $168 million Series B, including the conversion of $43 million in convertible loan…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here